Natera to commercialize plasma exome sequencing

Create PDF

The plasma exome service can be ordered as a standalone assay or reflexively for Signatera ctDNA-positive cases. With the combined service researchers can use Signatera to monitor patients for the presence or absence of ctDNA, and for positive patients they can reflex to a plasma exome to characterize tumor evolution using the same DNA library sample.

Natera, 844-778-4700